Source: Annual Congress 2006 - Cystic fibrosis: aerosol treatment and non–pulmonary complications
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. E. Geller, K. C. Kesser (Orlando, United States Of America). Predicting intrapulmonary aerosol delivery of the bacterial efflux pump inhibitor MP-601,205 for CF. Eur Respir J 2006; 28: Suppl. 50, 1517

Member's Comments

No comment yet.

Related content which might interest you: Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis Source: Eur Respir J 2002; 19: 294-302 Year: 2002 Application of 99mTc-DTPA aerosol in evaluation of pulmonary epithelial permeability Source: Eur Respir J 2003; 22: Suppl. 45, 593s Year: 2003 A human lung reperfusion model for monitoring the initial pulmonary absorption of drugs from aerosol devices Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005 Microbial evaluation of proton pump inhibitors and the risk of pneumonia Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Effect of n-butyldeoxynojirimycin on chloride efflux from CF airway epithelial cells Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Nasal transepithelial potential difference does not reflect beta2-adrenergic stimulation of transepithelial sodium transport-driven alveolar fluid clearance in mice Source: Eur Respir J 2001; 18: Suppl. 33, 257s Year: 2001 The state of mucociliary transport in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 418s Year: 2004 Minimizing aerosol leakage for nebulizer treatment in the COVID-19 pandemic Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Terbutaline increased fluid transport and surfactant secretion in a rat whole lung lavage model Source: Eur Respir J 2006; 28: Suppl. 50, 423s Year: 2006 Augmented susceptibility to hyperoxia-induced pulmonary edema in mice with deficient amiloride-sensitive sodium transport-dependent alveolar fluid clearance Source: Eur Respir J 2001; 18: Suppl. 33, 317s Year: 2001 Pulmonary epithelial permeability with 99mTc-DTPA aerosol in patients with spontaneous pneumothorax Source: Eur Respir J 2003; 22: Suppl. 45, 592s Year: 2003 High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects Source: Eur Respir J 2004; 23: 916-920 Year: 2004 Laninamivir’s prolonged intrapulmonary retention: Intrapulmonary pharmacokinetics (PK) and the intracellular disposition to support the long-lasting efficacy after an inhaled administration of its prodrug laninamivir octanoate (LO) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Aerosolized perfluorocarbon improves gas exchange and reduces lung injury more effectively than high frequency oscillatory ventilation Source: Eur Respir J 2002; 20: Suppl. 38, 37s Year: 2002 Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung Source: Eur Respir J 2016; 47:1392-1401 Year: 2016